欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/0733/001
药品名称
Mesavancol
活性成分
mesalazine 1200.0 mg
剂型
Gastro-resistant tablet
上市许可持有人
Giuliani SPA Via Palagi 2 20129 Milan
参考成员国 - 产品名称
Netherlands (NL)
Mesavancol
互认成员国 - 产品名称
Italy (IT)
许可日期
2006/12/14
最近更新日期
2024/04/11
药物ATC编码
A07EC02 mesalazine
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
common_pl
Date of last change:2023/03/06
Final SPC
|
common_spc
Date of last change:2023/03/06
Final Product Information
|
common-spc-proposed-clean
Date of last change:2021/03/03
Final Product Information
|
common-pl-proposed-clean
Date of last change:2021/03/03
Final Labelling
|
common-interpack
Date of last change:2020/09/07
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase